12/22/14


Infraredx, which markets a FDA-cleared optical catheter that identifies lipid core coronary plaques, filed on Monday with the SEC to raise up to $55 million in an initial public offering. The Burlington, MA-based company, which was founded in 1998 and booked $5 million in sales for the 12 months ended September 30, 2014, plans to list on the NASDAQ under the symbol [REDX]. Infraredx initially filed confidentially on November 12, 2014. RBC Capital Markets, Canaccord Genuity and BMO Capital Markets are the joint bookrunners on the deal. No pricing terms were disclosed....more


Keywords: REDX

12/22/14


Tobira Therapeutics, a biotech developing an immunotherapy treatment for liver disease (NASH) and HIV, updated its financials and added two underwriters ahead of its upcoming IPO in an amendment filed on Monday. The company had initially planned to raise $60 million in late July at a $150 million market cap, but postponed its IPO citing market conditions. In late October, it revived its IPO plans, but has yet to disclose terms.  Business Tobira is enrolling patients in Phase 2b trials for its once-daily pill for nonalcoholic steatohepatitis, or NASH. It expects ...more


Keywords: TBRA

12/22/14 Analyst IPO Blog


Supported by stable equity returns, global IPO issuance reached the highest levels since 2010. Annual IPO proceeds increased 48.7% to $204.8 billion. North America was the largest contributor to IPO issuance with the United States accounting for 39% of global proceeds. Europe, the Middle East and Africa also experienced jumps in IPO proceeds after facing struggles in recent years due to sovereign debt concerns and economic instability, while IPO issuance in Latin America stagnated as Brazil entered an economic recession and political unrest dampened investor sentiment. Once again, financial ...more


Keywords: BABA, LC, GPRO, ZOES, HABT, VA, MBLY, CFG, SYF, ALLY, PGRE

12/19/14


Asante Solutions, which markets a recently-approved insulin pump system with pre-filled cartridges, filed on Friday with the SEC to raise up to $45 million in an initial public offering. The Sunnyvale, CA-based company, which was founded in 2006 and booked $1 million in sales for the 12 months ended September 30, 2014, plans to list on the NASDAQ under the symbol [PUMP]. Asante Solutions initially filed confidentially on October 10, 2014. Leerink Partners, Cowen & Company, Wells Fargo Securities and Oppenheimer & Co. are the joint bookrunners on the deal. No pricing terms were ...more


Keywords: PUMP, TNDM

Archived News Headlines
Performance Disclosure: Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than the original cost. Investors should consider the investment objectives, risks, charges and expenses carefully before investing.

As stated in the Prospectus, the total annual operating expenses for the Fund was 3.48%. The Adviser has contractually agreed to keep net expenses from exceeding 2.50% of the Fund’s average daily net assets for at least a year from the date of the Prospectus and for an indefinite period thereafter subject to annual re-approval of the agreement by the Board of Trustees. An investor cannot invest directly in an index. Index returns do not represent Fund returns. The Index does not charge management fees or brokerage expenses, nor does the Index lend securities, and no revenues from securities lending were added to the performance shown.

Definitions: Net Asset Value (NAV) of the fund is calculated by dividing the total value of all the securities in its portfolio, less any liabilities, by the number of fund shares outstanding. Market Price is current value at which an asset or service can be bought or sold. Premium/Discount is provided to show the comparison of the daily net asset value (NAV) and the midpoint of the closing bid/ask for each of the funds. The Renaissance IPO Index® (IPOUSA) is a stock market index based upon a portfolio of U.S.-listed newly public companies that includes securities prior to their inclusion in core U.S. equity portfolios. The Renaissance International IPO Index® (IPOXUS) is a stock market index based upon a portfolio of newly public companies listed on non-U.S. exchanges. The S&P 500® Index (SPX) is a stock market index based on the market capitalizations of 500 large companies whose common stock is publicly traded on the NYSE.

Risk Disclosure: Investments in the Renaissance IPO ETF, symbol "IPO", the Renaissance International IPO ETF, symbol "IPOS" (the “ETFs”), and the Global IPO Fund, symbol "IPOSX" (the “Mutual Fund”) are subject to investment risk, including possible loss of the principal amounts invested. The ETFs and the Mutual Fund (the “Funds”) invest in companies that have recently completed initial public offerings. These stocks are unseasoned equities lacking trading history, a track record of reporting to investors and widely available research coverage which many result in extreme price volatility. Due to a greater number of IPOs in certain segments, the Funds may also be subject to information technology and financial sector risk, small and mid-capitalization company risk, and, for the Renaissance International IPO ETF, emerging markets risk. The Funds may hold securities in the form of Depository Receipts, REITs, and Partnership Units which have greater risks than common shares. The strategies have high portfolio turnover and securities lending risks. The returns of the ETFs may not match the return of the respective indices. The ETFs are classified as non-diversified investment companies subject to concentration risk.

Prospectus: Investors should consider the investment objectives, risks, charges and expenses carefully before investing. For a prospectus and/or summary prospectus with this and other information, please visit www.renaissancecapital.com. Read the prospectus carefully before investing. Renaissance Capital Investments, Inc., distributor for the Mutual Fund. Foreside Fund Services, LLC, distributor for the ETFs, 1-866-486-6645.
Attribution Policy: The information contained herein is proprietary and copyrighted. The media is welcome to use our information and ideas, provided that the following sourcing is included: Renaissance Capital - manager of IPO-focused ETFs.
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO), the Renaissance International IPO ETF (symbol: IPOS), or the Global IPO Fund (symbol: IPOSX), may have investments in securities of companies mentioned.